S.A. Mason LLC lessened its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 2.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 3,997 shares of the company’s stock after selling 99 shares during the quarter. S.A. Mason LLC’s holdings in Zoetis were worth $676,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Blue Bell Private Wealth Management LLC lifted its stake in Zoetis by 222.5% during the fourth quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after purchasing an additional 89 shares during the last quarter. Independence Bank of Kentucky grew its holdings in Zoetis by 371.4% in the fourth quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock valued at $33,000 after purchasing an additional 130 shares during the last quarter. Private Wealth Management Group LLC acquired a new stake in Zoetis in the fourth quarter valued at $33,000. Ramirez Asset Management Inc. purchased a new stake in shares of Zoetis in the third quarter valued at $35,000. Finally, Gladius Capital Management LP purchased a new stake in shares of Zoetis in the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.
Insider Activity at Zoetis
In related news, EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $151.17, for a total transaction of $139,529.91. Following the completion of the sale, the executive vice president now owns 14,800 shares of the company’s stock, valued at $2,237,316. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.16% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on ZTS
Zoetis Price Performance
Shares of ZTS stock traded up $9.51 during mid-day trading on Thursday, hitting $180.41. 665,103 shares of the stock traded hands, compared to its average volume of 2,931,672. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The firm has a market cap of $82.32 billion, a price-to-earnings ratio of 34.76, a price-to-earnings-growth ratio of 2.61 and a beta of 0.88. The company’s 50-day simple moving average is $167.30 and its 200-day simple moving average is $179.00. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.94 and a current ratio of 3.33.
Zoetis (NYSE:ZTS – Get Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.04. The business had revenue of $2.19 billion for the quarter, compared to analysts’ expectations of $2.14 billion. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS. As a group, equities research analysts expect that Zoetis Inc. will post 5.76 earnings per share for the current year.
Zoetis Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be given a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, July 18th. This represents a $1.73 dividend on an annualized basis and a yield of 0.96%. Zoetis’s payout ratio is 33.14%.
Zoetis Company Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Stories
- Five stocks we like better than Zoetis
- Roth IRA Calculator: Calculate Your Potential Returns
- Micron Stock Alert: Seize the Opportunity Before It Skyrockets
- What Makes a Stock a Good Dividend Stock?
- 3 Reasons Amazon Stock Is a Prime Buying Opportunity
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Whirlpool Stock Surges 20% on Takeover Speculation by Bosch
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.